AI-generated summary
The authors report an open-label trial of a device combining hybrid energy and trifractional technologies for acne scars in eight Filipino patients. Dermatologists and patients graded photographs, and the authors report improvement in most subjects after the full protocol, with satisfaction and comfort reported. The small, uncontrolled design limits how strongly these findings can be interpreted.
- Participants
- 8
- Who or what was studied
- Eight Filipino patients with acne scars
- Limits stated in the abstract
- Small open-label study of eight subjects with no control group, with grading partly by the treating investigator.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.